TapewireFind a company

person · Reporting owner

CRESSEY BRYAN C

Disclosed activity across 2 companies

Tapewire entity
110945
SEC CIK
0001072745

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
SELECT MEDICAL HOLDINGS CORPSEM · Entity 33845DirectorAugust 01, 2023August 02, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

SELECT MEDICAL HOLDINGS CORP

Report date August 01, 2023 · Filed August 02, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect75,035 Reported balance After 2023-08-01 transaction · row 1
1 source row

Row 1 · 2023-08-01 · Grant · Acquired 216 · Balance 75,035

F1: The grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a pro-rated quarterly retainer of $18,000.

Common StockSEC Table I · non-derivativeIndirectBy the Bryan Cressey and Iliana Sweis Cressey Foundation70,000 Reported balance Holding disclosure · report date 2023-08-01 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 70,000

F2: The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Common StockSEC Table I · non-derivativeIndirectBy Cressey Investments LLC383,850 Reported balance Holding disclosure · report date 2023-08-01 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 383,850

F3: The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a pro-rated quarterly retainer of $18,000.

F2: The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The reporting person beneficially owns the shares indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

BELDEN INC.

Report date May 25, 2022 · Filed May 27, 2022

Section 16 reporting ended · disclosed 2022-05-27. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect11,133 Reported balance After 2022-05-25 transaction · row 1
1 source row

Row 1 · 2022-05-25 · Grant · Acquired 2,655 · Balance 11,133

F1: Grant of shares under the Company's 2021 Long Term Incentive Plan. Based on value of $145,000 divided by the closing price of Belden stock on May 25, 2022 ($54.61).

Common StockSEC Table I · non-derivativeIndirectInvestment LLC194,211 Reported balance Holding disclosure · report date 2022-05-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 194,211

Filing footnotes · ownership attribution and instrument terms

F1: Grant of shares under the Company's 2021 Long Term Incentive Plan. Based on value of $145,000 divided by the closing price of Belden stock on May 25, 2022 ($54.61).

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 02, 2017 Filed Aug 4, 2017 16:48 UTC SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 GrantCommon Stock 1,139 $15.80 $17,996.20
Disclosure

SEC source: 0001179110-17-011139 · edgar.xml · nonDerivative · entry 2

CRESSEY BRYAN C · CIK 0001072745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 623,294

F2 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000.

Read SEC document
August 02, 2017 Filed Aug 4, 2017 16:48 UTC SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-011139 · edgar.xml · nonDerivative · entry 1

CRESSEY BRYAN C · CIK 0001072745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 622,155

F1 · shares: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 2, 2018, the first anniversary of the grant date.

Read SEC document
May 26, 2017 Filed May 31, 2017 19:04 UTC BELDEN INC. BDC · Entity 4002 GrantCommon Stock 2,403 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-036380 · doc4.xml · nonDerivative · entry 1

CRESSEY BRYAN C · CIK 0001072745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,925

F1 · shares: Grant of Restricted Stock Units (RSUs) under the Company's 2011 Long Term Incentive Plan. Based on value of $168,900 divided by the closing price on the grant date, May 26, 2017 ($70.30). RSUs generally vest one year after the date of award, but are subject to accelerated vesting under certain circumstances, including death, disability and retirement.

Read SEC document
May 03, 2017 Filed May 4, 2017 18:07 UTC SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 GrantCommon Stock 1,319 $13.65 $18,004.35
Disclosure

SEC source: 0001179110-17-006591 · edgar.xml · nonDerivative · entry 1

CRESSEY BRYAN C · CIK 0001072745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 612,155

F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 16:42 UTC SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 GrantCommon Stock 1,401 $12.85 $18,002.85
Disclosure

SEC source: 0001179110-17-002668 · edgar.xml · nonDerivative · entry 1

CRESSEY BRYAN C · CIK 0001072745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 610,836

F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000.

Read SEC document
November 02, 2016 Filed Nov 3, 2016 16:51 UTC SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 GrantCommon Stock 1,475 $12.20 $17,995.00
Disclosure

SEC source: 0001179110-16-031157 · edgar.xml · nonDerivative · entry 1

CRESSEY BRYAN C · CIK 0001072745 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 609,435

F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.